Project Number: 5410-32000-015-04
Project Type: Reimbursable

Start Date: Sep 24, 2007
End Date: Dec 31, 2009

Objective:
The objective of this project is to evaluate RVF Clone 13 vaccine viability as a possible U.S. veterinary vaccine and to assess the safety of the vaccine, and thus facilitate USDA, Center for Veterinary Biologics (CVB) to consider licensure in the U.S.

Approach:
ABADRL will perform and coordinated exploratory research centered on: i) insect vector susceptibility, competency and transmissibility of Clone 13 vaccine strain, ii) reversion to virulence potential of Clone 13 vaccine strain, iii) ability of Clone 13 vaccine strain to prevent virulent RVF virus replication in young animals, and iv) onset of immunity studies.